Director of Regulatory Affairs
Carthera, Rhone-Alpes, France
Sandra Thiollière is a Regulatory Affairs professional with over 15 years of experience in the medical devices industry. She began her career as an R&D project manager before transitioning to QA/RA roles across orthopedics, spine, and radiology, working in both SMEs and global organizations. Currently, Sandra serves as Director of Regulatory Affairs at Carthera, a French clinical-stage company developing innovative ultrasound-based drug-device combination solutions for the treatment of brain diseases. Sandra has successfully guided Carthera through the granting of multiple key EU and US designations, including Breakthrough Device, Orphan Drug, Orphan Device, and the French Forfait Innovation program.
Orphan Devices - Finding Rarity: A Case Study in Achieving Orphan Device Designation in the EU
Thursday, May 7, 2026
12:00 - 13:00 WEST